ICU Medical (ICUI) Revenue & Revenue Breakdown
ICU Medical Revenue Highlights
Latest Revenue (Y)
$2.38B
Latest Revenue (Q)
$604.70M
Main Segment (Y)
Equipment revenue
Main Geography (Y)
UNITED STATES
ICU Medical Revenue by Period
ICU Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $2.38B | 5.44% |
| 2023-12-31 | $2.26B | -0.92% |
| 2022-12-31 | $2.28B | 73.21% |
| 2021-12-31 | $1.32B | 3.56% |
| 2020-12-31 | $1.27B | 0.38% |
| 2019-12-31 | $1.27B | -9.56% |
| 2018-12-31 | $1.40B | 8.31% |
| 2017-12-31 | $1.29B | 240.72% |
| 2016-12-31 | $379.37M | 11.04% |
| 2015-12-31 | $341.67M | 10.48% |
| 2014-12-31 | $309.26M | -1.42% |
| 2013-12-31 | $313.72M | -1.00% |
| 2012-12-31 | $316.87M | 4.86% |
| 2011-12-31 | $302.19M | 6.19% |
| 2010-12-31 | $284.58M | 22.92% |
| 2009-12-31 | $231.51M | 13.08% |
| 2008-12-31 | $204.73M | 8.82% |
| 2007-12-31 | $188.14M | -6.68% |
| 2006-12-31 | $201.61M | 27.98% |
| 2005-12-31 | $157.53M | 108.51% |
| 2004-12-31 | $75.55M | -29.63% |
| 2003-12-31 | $107.35M | 22.26% |
| 2002-12-31 | $87.81M | 27.16% |
| 2001-12-31 | $69.06M | 22.89% |
| 2000-12-31 | $56.19M | 19.56% |
| 1999-12-31 | $47.00M | 18.09% |
| 1998-12-31 | $39.80M | 30.92% |
| 1997-12-31 | $30.40M | 23.58% |
| 1996-12-31 | $24.60M | 15.49% |
| 1995-12-31 | $21.30M | 29.09% |
| 1994-12-31 | $16.50M | 44.74% |
| 1993-12-31 | $11.40M | - |
ICU Medical generated $2.38B in revenue during NA 2024, up 5.44% compared to the previous quarter, and up 188.12% compared to the same period a year ago.
ICU Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $604.70M | -3.99% |
| 2024-12-31 | $629.80M | 6.90% |
| 2024-09-30 | $589.13M | -1.23% |
| 2024-06-30 | $596.46M | 5.39% |
| 2024-03-31 | $565.96M | -3.75% |
| 2023-12-31 | $587.99M | 6.27% |
| 2023-09-30 | $553.31M | 0.73% |
| 2023-06-30 | $549.31M | -3.40% |
| 2023-03-31 | $568.65M | -1.62% |
| 2022-12-31 | $578.01M | -3.32% |
| 2022-09-30 | $597.86M | 6.57% |
| 2022-06-30 | $561.00M | 3.29% |
| 2022-03-31 | $543.12M | 59.50% |
| 2021-12-31 | $340.52M | 1.33% |
| 2021-09-30 | $336.06M | 4.47% |
| 2021-06-30 | $321.68M | 1.14% |
| 2021-03-31 | $318.05M | -0.75% |
| 2020-12-31 | $320.45M | 0.59% |
| 2020-09-30 | $318.57M | 5.01% |
| 2020-06-30 | $303.38M | -7.68% |
| 2020-03-31 | $328.61M | 4.15% |
| 2019-12-31 | $315.52M | 2.62% |
| 2019-09-30 | $307.47M | -1.54% |
| 2019-06-30 | $312.28M | -5.64% |
| 2019-03-31 | $330.93M | -2.78% |
| 2018-12-31 | $340.38M | 4.04% |
| 2018-09-30 | $327.17M | -9.24% |
| 2018-06-30 | $360.46M | -3.11% |
| 2018-03-31 | $372.03M | 0.52% |
| 2017-12-31 | $370.12M | 7.83% |
| 2017-09-30 | $343.24M | 3.54% |
| 2017-06-30 | $331.51M | 33.82% |
| 2017-03-31 | $247.74M | 158.90% |
| 2016-12-31 | $95.69M | -1.46% |
| 2016-09-30 | $97.11M | 0.40% |
| 2016-06-30 | $96.72M | 7.64% |
| 2016-03-31 | $89.86M | -0.59% |
| 2015-12-31 | $90.39M | 5.08% |
| 2015-09-30 | $86.02M | 2.67% |
| 2015-06-30 | $83.78M | 2.82% |
| 2015-03-31 | $81.48M | 1.99% |
| 2014-12-31 | $79.90M | 3.15% |
| 2014-09-30 | $77.46M | -1.55% |
| 2014-06-30 | $78.68M | 7.44% |
| 2014-03-31 | $73.23M | -6.04% |
| 2013-12-31 | $77.94M | -5.89% |
| 2013-09-30 | $82.81M | 5.28% |
| 2013-06-30 | $78.66M | 5.87% |
| 2013-03-31 | $74.30M | -10.13% |
| 2012-12-31 | $82.67M | 1.56% |
| 2012-09-30 | $81.41M | 5.34% |
| 2012-06-30 | $77.28M | 2.34% |
| 2012-03-31 | $75.51M | -1.25% |
| 2011-12-31 | $76.47M | 0.02% |
| 2011-09-30 | $76.46M | -1.72% |
| 2011-06-30 | $77.80M | 8.85% |
| 2011-03-31 | $71.47M | -5.49% |
| 2010-12-31 | $75.62M | -0.15% |
| 2010-09-30 | $75.74M | 9.98% |
| 2010-06-30 | $68.86M | 6.99% |
| 2010-03-31 | $64.36M | -7.81% |
| 2009-12-31 | $69.81M | 29.37% |
| 2009-09-30 | $53.97M | 1.06% |
| 2009-06-30 | $53.40M | -1.72% |
| 2009-03-31 | $54.34M | -4.25% |
| 2008-12-31 | $56.74M | 3.67% |
| 2008-09-30 | $54.73M | 12.64% |
| 2008-06-30 | $48.59M | 8.82% |
| 2008-03-31 | $44.65M | -1.96% |
| 2007-12-31 | $45.55M | - |
ICU Medical generated $604.70M in revenue during Q1 2025, up -3.99% compared to the previous quarter, and up 102.84% compared to the same period a year ago.
ICU Medical Revenue Breakdown
ICU Medical Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Other deferred revenue | $503.00K | $1.92M | - | - | - |
| Government Grant Revenue | $7.34M | $944.00K | - | - | - |
| Software revenue | $29.91M | $19.95M | - | - | - |
| Equipment revenue | $55.93M | $35.87M | - | - | - |
| IV Solutions | - | - | $363.47M | $359.48M | $388.97M |
| Critical Care | - | - | $47.33M | $49.32M | $48.60M |
| Infusion Consumables-Smiths Medical | - | - | $340.12M | - | - |
| Infusion Systems | - | - | $351.08M | $352.32M | $359.69M |
| Infusion Consumables | - | - | $566.62M | $555.19M | $473.74M |
| Vascular Access | - | - | $326.76M | - | - |
| Vital Care | - | - | $284.61M | - | - |
ICU Medical's latest annual revenue breakdown by segment (product or service), as of Dec 24: Equipment revenue (59.70%), Software revenue (31.93%), Government Grant Revenue (7.84%), and Other deferred revenue (0.54%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other deferred revenue | $390.00K | $239.00K | - | $503.00K | $155.00K | - | $1.67M | $2.59M | $3.71M | - | - | - | - | - | - | - | - | - | - | - |
| Government Grant Revenue | $-1.02M | $-509.00K | - | $7.86M | - | - | $944.00K | $1.45M | $1.42M | - | - | - | - | - | - | - | - | - | - | - |
| Software revenue | $2.47M | $1.20M | - | $24.56M | $5.57M | - | $12.80M | $8.00M | $8.32M | - | - | - | - | - | - | - | - | - | - | - |
| Equipment revenue | $30.36M | $19.94M | $7.77M | $38.83M | $9.34M | - | $25.62M | $15.61M | $17.46M | - | - | - | - | - | - | - | - | - | - | - |
| Infusion Systems | - | $166.30M | $88.97M | $87.85M | $87.25M | $87.01M | $92.64M | $90.69M | $84.66M | $84.33M | $91.83M | $88.39M | $91.09M | - | - | - | - | - | - | - |
| Vital Care | - | $172.18M | $77.50M | $69.52M | $67.94M | $69.65M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Infusion Consumables | - | $266.23M | $140.57M | $141.07M | $144.46M | $140.52M | $147.77M | $144.85M | $136.20M | $126.37M | $123.19M | $116.05M | $110.99M | - | - | - | - | - | - | - |
| IV Solutions | - | - | - | - | - | - | - | - | - | $84.51M | $96.37M | $94.11M | $88.48M | $87.64M | $89.24M | $88.42M | $94.18M | $93.60M | $101.90M | $89.18M |
| Critical Care | - | - | - | - | - | - | - | - | - | $11.92M | $10.88M | $12.37M | $12.16M | $12.47M | $11.29M | $12.39M | $13.17M | $11.83M | $12.22M | $12.12M |
| Infusion Consumables-Smiths Medical | - | - | - | - | - | - | - | - | - | $99.13M | $96.89M | $77.81M | $66.29M | - | - | - | - | - | - | - |
| Vascular Access | - | - | - | - | - | - | - | - | - | $75.42M | $95.28M | $77.06M | $79.01M | - | - | - | - | - | - | - |
ICU Medical's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Equipment revenue (94.29%), Software revenue (7.68%), Other deferred revenue (1.21%), and Government Grant Revenue (-3.18%).
ICU Medical Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| UNITED STATES | $1.53B | $1.44B | $1.46B | $941.81M | $910.63M |
| Other foreign countries | $223.59M | $203.84M | $195.31M | $227.01M | $227.61M |
| EMEA | $393.53M | $373.57M | $367.41M | $147.49M | $132.76M |
| APAC | - | - | $257.21M | - | - |
| Foreign | - | - | - | $374.50M | $360.38M |
ICU Medical's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (71.29%), EMEA (18.31%), and Other foreign countries (10.40%).
Quarterly Revenue by Country
| Country | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $335.43M | $388.25M | $796.43M | $369.51M | $366.15M | $376.98M | $355.98M | $347.87M | $359.19M | $371.72M | $376.69M | $363.87M | $347.79M | $244.49M | $245.30M | $224.67M | $227.35M | $234.80M | $237.45M | $208.22M |
| Asia Pacific | $58.40M | $59.41M | $60.29M | $51.85M | $59.06M | $60.03M | $58.62M | $66.57M | - | - | - | - | - | - | - | - | - | - | - | - |
| Other foreign countries | $55.97M | $61.36M | $115.72M | $57.62M | $50.26M | $50.32M | $50.25M | $51.42M | $51.85M | $109.72M | $109.13M | $57.34M | $54.52M | $59.25M | $55.90M | $52.00M | $48.52M | $66.57M | - | - |
| EMEA | $99.06M | $95.69M | $193.43M | $101.71M | $98.39M | $96.58M | $88.01M | $89.99M | $98.99M | $91.92M | $101.87M | $87.42M | $86.20M | $38.69M | $36.24M | $37.76M | $34.80M | $33.66M | $32.60M | $28.58M |
| Americas | - | - | - | - | - | - | - | - | - | - | $429.42M | - | - | - | - | - | - | - | - | - |
| Latin America | - | - | - | - | - | - | - | - | - | - | $23.60M | - | - | - | - | - | - | - | - | - |
| CANADA | - | - | - | - | - | - | - | - | - | - | $29.13M | - | - | - | - | - | - | - | - | - |
| Foreign | - | - | - | - | - | - | - | - | - | - | - | $197.14M | $195.33M | $96.03M | $90.76M | $97.01M | $90.69M | $85.65M | $81.12M | $95.16M |
ICU Medical's latest quarterly revenue breakdown by geography, as of Jun 25: UNITED STATES (61.11%), EMEA (18.05%), Asia Pacific (10.64%), and Other foreign countries (10.20%).
ICU Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PRGO | Perrigo | $4.37B | $1.06B |
| XRAY | DENTSPLY SIRONA | $3.79B | $936.00M |
| SGRY | Surgery Partners | $3.11B | $826.20M |
| ICUI | ICU Medical | $2.38B | $604.70M |
| HAE | Haemonetics | $1.36B | $321.39M |
| LIVN | LivaNova | $1.25B | $316.86M |
| WRBY | Warby Parker | $771.32M | $223.78M |
| APLS | Apellis Pharmaceuticals | $709.95M | $171.39M |
| TARS | Tarsus Pharmaceuticals | $182.95M | $78.33M |
| HTFL | Heartflow | $125.81M | $43.42M |
| MLYS | Mineralys Therapeutics | - | - |